Inventor
ESSWEIN ANGELIKA
DE15 patents
⚠️ This page may combine multiple inventors who share the name “ESSWEIN ANGELIKA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ROCHE DIAGNOSTICS GMBH
6 patentsUS5972947AOct 26, 1999
Oxazolidinone derivatives, processes for the production thereof and pharmaceutical agents containing these compounds
ROCHE DIAGNOSTICS GMBH39 citations92
US6429288B1Aug 6, 2002
Peptides containing an arginine mimetic for the treatment of bone metabolic disorders, their production, and drugs containing these compounds
ROCHE DIAGNOSTICS GMBH24 citations90
US6110924AAug 29, 2000
Barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds
ROCHE DIAGNOSTICS GMBH15 citations73
US6197759B1Mar 6, 2001
Osteoblast-specific mitogens and drugs containing such compounds
ROCHE DIAGNOSTICS GMBH4 citations62
US6911553B1Jun 28, 2005
Osteoblast-specific mitogens and drugs containing such compounds
ROCHE DIAGNOSTICS GMBH0 citations51
US6472396B1Oct 29, 2002
Barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds
ROCHE DIAGNOSTICS GMBH1 citations51
BOEHRINGER MANNHEIM GMBH
4 patentsUS5538957AJul 23, 1996
Phosphonosuccinic acid derivatives, processes for their preparation and medicaments containing these compounds
BOEHRINGER MANNHEIM GMBH27 citations92
US5683994ANov 4, 1997
Phosphosuccinic acid derivatives, processes for the production thereof and pharmaceutical agents containing these compounds
BOEHRINGER MANNHEIM GMBH3 citations62
US5698541ADec 16, 1997
2,4-diphosphonoglutaric acid derivatives, processes for their production and pharmaceutical agents containing these compounds
BOEHRINGER MANNHEIM GMBH1 citations51
US5627170AMay 6, 1997
Phosphonic acid compound containing heterocyclic substituents, pharmaceutical composition contains same and a method of treating calcium metabolism disturbance
BOEHRINGER MANNHEIM GMBH1 citations51